Drug Trial Radar · NCT02536079
NeuroAiD Safe Treatment Registry
Last checked: Nov 19, 2026Latest source record: Feb 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,000
Planned (sponsor's estimate)
Start
Jun 2014
Primary completion
Dec 2024
Study completion Dec 2025
Sponsor
- Lead sponsor
- CHIMES SocietyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Moleac Pte Ltd.
- First posted
- Aug 31, 2015
Design
- Study type
- Observational
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The NeST registry is a pro-active industry-academic collaboration to assess the use and safety of NeuroAiD in the real world setting. An online entry system was set up to allow easy data entry and retrieval of clinical information.
Conditions
- Brain Injury
- NeuroAiD Use
Interventions
NeuroAiDDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patients experiencing adverse eventsTime frame: 3 months
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
National Brain Center Hospital
Jakarta, Indonesia · Recruiting
University Kebangsaan Malaysia Medical Centre
Kuala Lumpur, Malaysia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.